UBS Downgrades St. Jude Medical (STJ) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Barclays Upgrades St. Jude Medical (STJ) to Equalweight
May 11, 2016 6:52 AM EDTBarclays upgraded St. Jude Medical (NYSE: STJ) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.
Shares of St. Jude Medical closed at $75.51 yesterday.
... MoreSunTrust Robinson Humphrey Downgrades St. Jude Medical (STJ) to Neutral
May 10, 2016 7:04 AM EDTSunTrust Robinson Humphrey downgraded St. Jude Medical (NYSE: STJ) from Buy to Neutral with a price target of $80.00 (from $70.00).
For an analyst ratings summary and ratings history on St. Jude Medical... More
